Back to search
FDAFDA · Food and drugs·Recall number D-0787-2021

Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15

Published September 8, 2021 · Recall initiated: August 2, 2021

Summary

FDA records drug Class II recall D-0787-2021, published September 8, 2021 and initiated August 2, 2021. Recalling firm: Macleods Pharma Usa Inc; Status: Terminated; Reported quantity: 444,000 tablets / 888 unit packs of 500 count; Lot: Lot # BCA82021A, Exp 06/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign matter

What to do

Voluntary: Firm initiated · Letter

Get an email if CLOPIDOGREL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CLOPIDOGREL
Manufacturer
Macleods Pharma Usa Inc
Distributor
Product was distributed nationwide.
UPC
0333342060440
Lot
Lot # BCA82021A, Exp 06/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15 recalled?

Yes. FDA published recall D-0787-2021 on September 8, 2021. Reported hazard: Presence of foreign matter

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CLOPIDOGREL. UPC: 0333342060440.